Disclaimer: This document is an English translation of the original document in Japanese and has been prepared solely for reference
purposes. In the event of any discrepancy between this English translation and the original in Japanese, the original shallprevail in all respects.

Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024 [Japanese GAAP]
November 10, 2023
SHIP HEALTHCARE HOLDINGS, INC.
Shares listed on: Tokyo Stock Exchange
Code:
3360
URL
https://www.shiphd.co.jp/en/
Representative:(Title) President(Name) Futoshi Ohashi
Contact:(Title) Executive Director(Name) Hiroshi YokoyamaTel.: +81-6-6369-0130
Scheduled date for filing quarterly report: November 13, 2023
Scheduled start date of dividend payments: –Supplementary briefing materials on results: Yes
Briefing on quarterly results: Yes (for institutional investors and analysts)
Name of listed company:(All figures are rounded down to the nearest million yen.)

1. Consolidated financial results for the second quarter of fiscal year ending March 31, 2024
(April 1, 2023 – September 30, 2023)(1) Consolidated operating results
Net sales(Million yen)

(Percentages represent year-on-year changes.)
Profit attributable toOrdinary profit
owners of parent

Operating profit%(Million yen)%

(Million yen)

Q2 FY ending March 2024
296,771
12.6
9,238
15.9
Q2 FY ended March 2023
263,520
12.3
7,971
5.0
Note: Comprehensive income: Q2 FY ending March 2024: ¥5,582 million ((17.6%))
Q2 FY ended March 2023: ¥6,774 million (84.6%)
Diluted net
Net income per shareincome per share
Q2 FY ending March 2024
Q2 FY ended March 2023

(Yen)

(Yen)

39.07
43.92

35.38
39.80

10,116
7,498%(Million yen)

%

34.9
1.6

3,686
4,143

(11.0)
0.6(2) Consolidated financial condition
Total assets

Net assets(Million yen)

Equity capital ratio(Million yen)%

Q2 FY ending March 2024
375,250
132,709
34.5
FY ended March 2023
381,977
131,115
33.5
Reference: Equity: Q2 FY ending March 2024: ¥129,406 million; FY ended March 2023: ¥128,037 million

2. Dividends
End Q1(Yen)––

End Q2
(Yen)
0.00
0.00

Annual dividends
End Q3(Yen)–

FY ended March 2023
FY ending March 2024
FY ending March 2024–
(forecast)
Note: Revisions made in most recently announced dividend forecasts: None
Note: Dividend breakdown for the fiscal year ending March 31, 2024 (forecast)Ordinary dividend ¥43.00 Commemorative dividend ¥5.00

Year-end
(Yen)
42.00

Total
(Yen)
42.00

48.00

48.00

3. Forecast of consolidated financial results for the fiscal year ending March 31, 2024
(April 1, 2023 – March 31, 2024)(Percentages represent changes from previous year.)
Profit attributable to Net income per
Net sales
Operating profit
Ordinary profit
owners of parent
share(Million yen)
(Million yen)
(Yen)
% (Million yen)
% (Million yen)%%
Full-year
600,000
4.8
23,50011.1
23,50014.0
12,5003.6
132.49Notes: Revisions made in most recently announced forecasts of business performance: Yes

Notes(1) Changes made in significant subsidiaries during consolidated cumulative quarter under review:(2) Special account processing applied in preparation of quarterly consolidated financial statements:(3) Changes made in accounting policies, accounting estimates, and/or restatements:(i) Changes in accounting policies associated with changes in accounting standards, etc.:(ii) Any changes in accounting policies other than those under (i) above:(iii) Changes in accounting estimates:(iv) Restatements:(4) Number of shares issued and outstanding (common stocks)(i) Number of shares issued and outstanding
Q2 FY endingat the end of the period (including treasury March 2024
stock)(ii) Number of treasury stock at the end of the Q2 FY ending
March 2024
period(iii) Average number of shares during theQ2 FY ending
March 2024
period (quarterly cumulative)

None
None
None
None
None
None

101,669,400 shares

FY ended March
2023

101,669,400 shares

7,319,175 shares

FY ended March
2023

7,319,175 shares

94,350,225 shares

Q2 FY ended
March 2023

94,350,268 shares* This financial result is not subject to quarterly review by certified public accountant or audit firm.
* Information on appropriate use of financial forecasts and other special notes:•

The forecasts of financial results and other forward-looking statements provided herein are based on information available atthe time this document was prepared, and certain assumptions considered reasonable. Actual results may differ significantly
from forecasts due to various factors. For assumptions underlying forecasts of financial results, notes on use of forecasts offinancial results, and other related information, please refer to “Information on consolidated financial forecasts and otherforward-looking statements” on page 3 of the [attached materials].

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

 Index of attached materials
1.

Qualitative information on quarterly results ..........................................................................................

2(1)

Description of business results ..............................................................................................................

2(2)

Analysis of financial position ................................................................................................................

3(3)

Information on consolidated financial forecasts and other forward-looking statements ........................

3

2.

Quarterly consolidated financial statements and notes thereto ..............................................................

4(1)

Quarterly consolidated balance sheet ....................................................................................................

4(2)

Quarterly consolidated statement of income and consolidated statement of comprehensive income ....

6

(3)

Quarterly consolidated statement of cash flows ....................................................................................

8(4)

Notes on quarterly consolidated financial statements ............................................................................

10(Notes on the going concern assumption) ............................................................................................

10(Notes on marked changes to shareholders' equity) .............................................................................

10(Segment information, etc.) .................................................................................................................

101

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

1. Qualitative information on business results(1) Description of business results
The Japanese economy during the second quarter of the current consolidated cumulative period, showed signs ofnormalization in socioeconomic activities due to easing of restrictions on movement caused by the COVID-19. On theother hand, the future remains uncertain, with energy prices remaining high due to Russia's invasion of Ukraine, soaring
food prices, economic slowdown expected due to financial tightening in various countries, and unstable exchange rates.
Healthcare industry in which the Group operates, due to the change in the position of COVID-19 under the Infectious
Diseases Act, reviews of the bed reservation fees for medical institutions and special treatment fees have been
implemented. Additionally, in various prefectures, guidelines have been established as part of the 8th phase of the Medical
Care Plan to address various challenges in regional healthcare that have become evident due to the spread of the COVID19 pandemic and to adapt to changes in the population structure.
In the Group business under such conditions, the business progressed as planned due to smooth progress of the projects in
the Total Pack Produce business. However, 2 consolidated subsidiaries in the Republic of the Union of Myanmar havebeen affected by the impact of Western financial sanctions and forced currency conversion resulting from the military
coup that occurred previously. Furthermore, with the recent strengthening of additional financial sanctions, it has become
increasingly difficult to recover foreign currency or make purchases. Given the prospect of such circumstances continuingin the future, it has been determined that the originally anticipated excess earning power cannot be expected. As a result,the full amount of goodwill, total of 2,635 million yen, has been recognized as an extraordinary loss through impairment.
In addition, this fiscal year marks the second term of the medium-term management plan "SHIP VISION 2024", theGroup continued to promote 4 core strategic initially set forth “Further high growth of core business”, “Further expand
value”, “Functional organization enhancement strategy”, and “Activities for sustainability”.
For the second quarter of the current consolidated cumulative period, the various factors noted above resulted in net salesof 296,771 million yen (up 12.6% YoY), operating profit of 9,238 million yen (up 15.9% YoY), ordinary profit of 10,116
million yen (up 34.9% YoY), and profit attributable to owners of the parent of 3,686 million yen (down 11.0% YoY).
Business results by segment are summarized below.
(i) Total Pack Produce businessIn Total Pack Produce business, the projects were steadily progressed. Although the manufacturers were still affectedby the long lead time in procuring electrical components, it has eased compared to the previous fiscal year. Also, thenumber of new outpatients and treatment cases in Osaka Heavy Ion Therapy Center increased due to the expansion ofareas covered by Japanese national medical insurance from April 2022. In addition, the business results of Kingrun
Group, which joined in the Group in July last year, has contributed since the first quarter consolidated cumulative
period for this fiscal year.
As a result, this segment recorded net sales of 56,665 million yen (up 16.5% YoY) and segment profit (operating
profit) of 3,443 million yen (up 28.3% YoY).
(ii) Medical Supply business
In Medical Supply business, the business was affected by the souring prices of raw materials and labor costs,
however, demand for medical supplies recovered due to an increase in the number of surgical cases.
As a result, this segment recorded net sales of 205,922 million yen (up 11.5% YoY) and segment profit (operating
profit) of 2,800 million yen (up 4.2% YoY).
(iii) Lifecare business
In Lifecare business, the nursing care homes maintained high occupancy rate, although it was affected by risingutility costs. Also, the sales increase in food supply thanks to the contribution of the performance of companies thatjoined the Group in the previous fiscal year, the group could overcome the soaring food prices.
As a result, this segment recorded net sales of 18,010 million yen (up 16.4% YoY) and segment profit (operating
profit) of 1,293 million yen (up 16.3% YoY).
(iv) Dispensing Pharmacy business
In Dispensing Pharmacy business, due to the new store openings and small scale of M&A, etc., the performance has
steadily increased.
As a result, this segment recorded net sales of 16,173 million yen (up 9.9% YoY) and segment profit (operating
profit) of 1,676 million yen (up 18.1% YoY).

2

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

(2) Analysis of Financial Position(i) Assets, liabilities, and net assets
Assets at the end of the consolidated second quarter under review stood at 375,250 million yen, down 6,727 million
yen from the end of the previous consolidated fiscal year. The primary reasons for this decrease included decrease of
15,467 million yen in notes, accounts receivable, and contract asset, 3,263 million yen in goodwill, despite increasesof 7,213 million yen in cash and deposits, 2,145 million yen in merchandise and finished goods.
Liabilities stood at 242,541 million yen, down 8,321 million yen from the end of the previous consolidated fiscal year.
The primary reasons for this decrease included decrease of 10,155 million yen in notes and accounts payable – trade,
despite increases of 4,160 million yen in electronically recorded obligations – operating.
Net assets stood at 132,709 million yen, up1,593 million yen from the end of the previous consolidated fiscal year.
The primary reasons for this increase included increases of 3,686 million yen in retained earnings from profit
attributable to owners of parent, 935 million yen in valuation differences on available-for-sale securities, despite
decrease of 3,962 million yen in retained earnings due to cash dividends paid.
As a result of all these factors, equity capital ratio at the end of the consolidated second quarter stood at 34.5%. (up1.0% from the end of the previous consolidated fiscal year)(ii) Cash flow
Cash flow proceeded by operating activities during the consolidated cumulative second quarter under review totaled
15,628 million yen (proceeds up 8,581 million yen from the same period in the previous consolidated fiscal year).
Major contributing factors include decrease of 15,301 million yen in notes and accounts receivable - trade, 7,392
million yen in profit before income taxes, despite the payment of 5,245 million yen for income taxes, and decrease of
6,104 million yen in notes and accounts payable – trade.
Cash flow used in investing activities totaled 1,627 million yen (expenses down 3,393 million yen from the same
period in the previous consolidated fiscal year). Major contributing factors include expense of 1,698 million yen forpurchase of property, plant, and equipment, 232 million yen for purchase of shares subsidiaries resulting in change inscope of consolidation, despite proceeds of 340 million yen from sale of tangible fixed assets.
Cash flow used in financing activities totaled 7,001 million yen (proceeds up 9,515 million yen from the same period
in the previous consolidated fiscal year). Major contributing factors include payment of 3,962 million yen for cash
dividends paid, and expense of 3,142 million yen for repayments of long-term loans payable.
As the result of the above factors, the balance of cash and cash equivalents at the end of the consolidated cumulative
second quarter stood at 86,175 million yen, up 7,154 million yen from the end of the previous consolidated fiscal
year.

(3) Information on consolidated financial forecasts and other forward-looking statements
In general, business performance matched financial forecasts made at the start of the period. The consolidated
financial forecasts for the fiscal year remain unchanged from the forecasts announced on May 12, 2023.

3

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

2. Quarterly consolidated financial statements and notes thereto(1) Quarterly consolidated balance sheet
Fiscal year ended
March 31, 2023
AssetsCurrent assets
Cash and deposits
Notes, accounts receivable, and contract asset
Electronically recorded monetary claims – operating
Lease investment assets
Merchandise and finished goods
Work in process
Raw materials and supplies
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant, and equipment
Buildings and structures, net
Land
Real estate for rent, net
Other, net
Total property, plant, and equipment
Intangible assets
Goodwill
Other
Total intangible assets
Investments and other assets
Investment securities
Long-term loans receivable
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

4(Unit: Million yen)
Q2 Fiscal year ending March
31, 2024 (Sep. 30, 2023)

80,839131,5395,374
3,102
21,3893,776
1,504
10,817(1,101)
257,241

88,052116,072
6,591
2,999
23,534
4,532
1,750
11,161(1,185)
253,51123,44618,20910,951
12,521
65,12723,51818,067
11,008
11,78564,38012,3203,828
16,1499,056
3,601
12,65825,424
7,117
12,605(1,689)43,458
124,735
381,977

27,097
6,982
12,315(1,695)44,699
121,738
375,250SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

Fiscal year ended
March 31, 2023
Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations - operating
Short-term loans payable
Income taxes payable
Provision for bonuses
Current portion of bonds with share acquisition rights
Other
Total current liabilities
Non-current liabilities
Long-term loans payable
Net defined benefit liability
Asset retirement obligations
Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders' equity
Capital stock
Capital surplus
Retained earnings
Treasury stock
Total shareholders' equity
Accumulated other comprehensive income
Valuation differences on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustments
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets

5(Unit: Million yen)
Q2 Fiscal year ending March
31, 2024 (Sep 30, 2023)

109,883
28,622
1,815
5,332
2,908
25,01623,441
197,020

99,72732,783
1,953
3,923
2,822
25,004
24,236
190,450

41,571
3,383
1,156
7,730
53,842
250,862

39,473
3,423
1,160
8,034
52,090242,541

15,55323,533
100,158(15,526)
123,718

15,55323,447
99,882(15,526)
123,356

2,978
1
1,305
32
4,319
3,077
131,115
381,977

3,913
2
2,096
37
6,049
3,302
132,709375,250SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

(2) Quarterly consolidated statement of income and consolidated statement of comprehensive income
Quarterly consolidated statement of income
Consolidated cumulative second quarter

Net sales
Cost of sales
Gross profit
Sales, general, and administrative expenses
Operating profit
Non-operating profit
Interest income
Dividend income
Equity gains of affiliated companies
Foreign exchange gain
Other
Total non-operating profit
Non-operating expenses
Interest expenses
Equity losses of affiliated companies
Foreign exchange loss
Other
Total non-operating expenses
Ordinary profit
Extraordinary profit
Gains on sales of non-current assets
Subsidy income
Other
Total extraordinary profit
Extraordinary losses
Impairment loss
Losses on retirement of non-current assets
Losses on sale of affiliated company shares
Other
Total extraordinary losses
Profit before income taxes
Income taxes - current
Income taxes - deferred
Total income taxes
ProfitLosses attributable to non-controlling interests
Profit attributable to owners of parent

6

Six months ended
September 30, 2022
263,520
236,793
26,72618,755
7,971(Unit: Million yen)Six months ended
September 30, 2023
296,771
267,232
29,53820,300
9,238

158
115
225
498

163
147
549
32
291
1,183

190
10
743
27
971
7,498

221
84
305
10,116

17
45
0
64

44
6
50

13
5
18
7,543
3,378
304
3,683
3,860
(283)
4,143

2,635
7
129
1
2,773
7,392
3,539
168
3,707
3,684
(1)
3,686

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

Quarterly consolidated statement of comprehensive income
Consolidated cumulative second quarter

Six months ended
September 30, 2022
3,860

Net income
Other comprehensive income
1,357
Valuation differences on available-for-sale securities
1,541
Foreign currency translation adjustments(4)Remeasurements of defined benefit plans
Share of other comprehensive income of entities accounted for using equity method
20
2,914
Total other comprehensive income
6,774
Comprehensive income(Breakdown)Comprehensive income attributable to owners of parent
Comprehensive income attributable to non-controlling interests

7

6,791
(16)

(Unit: Million yen)Six months ended
September 30, 2023
3,684
935
970
2
(10)
1,897
5,582
5,416
165

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

(3) Consolidated statement of cash flows(Unit: Million yen)Six months ended
September 30, 2023

Six months ended
September 30, 2022
Cash flows from operating activities
Profit before income taxes

7,543

7,392

Depreciation and amortization

2,189

2,653

Impairment loss
Amortization of goodwill
Share of loss (profit) of entities accounted for using equity method

-

2,635

1,176

1,066

10

(549)

Increase (decrease) in provision for bonuses

(465)

(88)

Increase (decrease) in allowance for doubtful accounts

201

89

Increase (decrease) in net defined benefit liability

40

71

Loss (profit) on sales of affiliated company sharesInterest and dividend income
Interest expenses

-

129

(273)

(310)

190

221

Decrease (increase) in notes and accounts receivable – trade

7,582

15,301

Decrease (increase) in inventories(3,202)(3,109)

Increase (decrease) in notes and accounts payable – trade(4,078)(6,104)98

102

Decrease (increase) in lease investment assets
Other

440

1,079

Subtotal

11,453

20,580432

512Interest and dividend income received
Interest expenses paid

(190)

(219)

Income taxes paid

(4,648)(5,245)

Net cash provided by operating activities

7,046

15,628

Payments into time deposits

(185)

(222)

Proceeds from withdrawal of time deposits

240

249

Purchase of property, plant, and equipment

Cash flows from investing activities(1,395)(1,698)Proceeds from sales of property, plant, and equipment

114

340

Purchase of intangible assets

(307)

(72)

Payments of short-term loans receivable

(107)

(17)

Collection of long-term loans receivable

198

218

Purchase of investment securities

(116)

(91)

Proceeds from shares of subsidiaries resulting in change inscope of consolidation
Purchase of shares of subsidiaries resulting in change inscope of consolidation
Sales of shares of subsidiaries resulting in change in scope of
consolidation
Other

382

-

(2,998)

(232)

-

(172)

(846)

71

(5,021)(1,627)

Net cash used in investing activities

8

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

(Unit: Million yen)Six months ended
September 30, 2023

Six months ended
September 30, 2022
Cash flows from financing activities
Increase (decrease) in short-term loans-net

8,830

185

Proceeds from long-term loans payable

471

62

Repayments of long-term loans payable(2,763)(3,142)(0)-(3,868)(3,962)

(22)

(25)

Purchase of treasury stock
Cash dividends paid
Cash dividends paid to non-controlling interests
Repayments of lease obligations

(132)

(117)

Net cash used in financing activities

2,514(7,001)

139

154

Effect of exchange rate change on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents

4,680

7,154

Cash and cash equivalents at the beginning of the period

72,80479,020Cash and cash equivalents at the end of the period

77,484

86,175

9

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

(4) Notes on consolidated financial statements(Notes on the going concern assumption)
Not applicable(Notes on marked changes to shareholders' equity)
Not applicable(Segment information, etc.)[Segment information]
I.

Previous consolidated cumulative second quarter (April 1, 2022 – September 30, 2022)

1 Net sales and profit (loss) by reportable segments(Unit: Million yen)
Reportable segments
Total Pack
Producebusiness

MedicalSupplybusiness

Dispensing
Pharmacybusiness

Lifecarebusiness

Adjustments*1

Amount recordedon consolidated
financialstatements*2

Total

Net sales(1) Sales to outside
customers(2) Intersegment
sales or transfers

48,651

184,681

15,472

14,715263,520－

263,520

1,341

722

28

49

2,141

(2,141)－

Subtotal

49,992

185,404

15,501

14,764

265,661(2,141)

263,520

2,684
2,687
1,111
1,419
7,903
67
7,971
Segment profit
Notes: 1 The figure of 67 million yen in adjustments to segment profit includes (29) million yen in cancellation ofintersegment transactions and 98 million yen in companywide costs not allocated among reportable segments. These
companywide costs consist mainly of parent company’s operating expenses and sales, general, and administrative
expenses not attributable to individual reportable segments.
2 Segment profit is adjusted against the operating profit reported on the quarterly consolidated statement of income.

2 Notes on changes in reportable segments, etc.
During the second quarter consolidated cumulative period, the Company has acquired shares of Kingrun Co., Ltd. and added
it to the scope of consolidation.
As a result of this event, assets in“Total Pack Produce Business”segment increased by 26,202 million yen compared to theend of the previous consolidated fiscal year.

3 Information on impairment loss on non-current assets or goodwill, per reportable segments(significant impairment loss on non-current assets)
Not applicable(significant fluctuations in the amount of goodwill)
During the second quarter consolidated cumulative period, the Company has acquired shares of Kingrun Co., Ltd. and added
it to the scope of consolidation.
The increase in goodwill in the “Total Pack Produce business” segment due to the event is 7,101 million yen in the second
quarter of the current consolidated cumulative period.
The amount of goodwill is a tentatively calculated amount as the allocation of the acquisition cost has not been completed asof the end of the second quarter consolidated fiscal year.
(significant gain on negative goodwill)
Not applicable10

SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2024

II.

Consolidated cumulative second quarter under review (April 1, 2023 – September 30, 2023)

1 Net sales and profit (loss) by reportable segments(Unit: Million yen)
Reportable segments
Total Pack
Producebusiness

MedicalSupplybusiness

Dispensing
Pharmacybusiness

Lifecarebusiness

Adjustments*1

Amount recordedon consolidated
financialstatements*2

Total

Net sales(1) Sales to outside
customers(2) Intersegment
sales or transfers

56,665205,92218,01016,173296,771－296,771

1,592

598

22

47

2,261

(2,261)－

Subtotal

58,257

206,520

18,033

16,220299,032(2,261)

296,771

3,443
2,800
1,293
1,676
9,213
25
9,238
Segment profit
Notes: 1 The figure of 25 million yen in adjustments to segment profit includes (57) million yen in cancellation ofintersegment transactions and 81 million yen in companywide costs not allocated among reportable segments. These
companywide costs consist mainly of parent company’s operating expenses and sales, general, and administrative
expenses not attributable to individual reportable segments.
2 Segment profit is adjusted against the operating profit reported on the quarterly consolidated statement of income.

2 Information on impairment loss on non-current assets or goodwill, per reportable segments(significant impairment loss on non-current assets)
In the Total Pack Produce business, considering the progress of the Myanmar operations compared to the initial business planand the outlook for future performance, it has been determined that the originally anticipated excess earning power cannot be
expected. As a result, an impairment loss has been recognized for goodwill.
The amount of the impairment loss recognized for goodwill due to this event is 2,635 million yen for the cumulative period of
the second quarter.
(significant fluctuations in the amount of goodwill)
As mentioned above (significant impairment loss related to on non-current assets), the Company has impaired the goodwill in
the Total Pack Produce business.
(significant gain on negative goodwill)
Not applicable11